Because one, there is a need
Professional purchasing experience
Pakistans diabetes market has come under significant limelight over the past year following the launch of the GLP-1 agonist weight-loss molecule Semaglutide by local pharmaceutical companies
Two more popular weight loss solutions are bariatric surgery and, more recently, GLP-1 medications
(2023) diabetes cohort data demonstrated that retatrutide at the 12mg dose reduced HbA1c by 2.2 percentage points, which exceeds the glycemic reduction observed with semaglutide 2.4mg in comparable diabetic populations
Many people taking GLP-1 medications such as Ozempic, Wegovy, or Zepbound experience shifts in appetite, energy, and daily eating patterns